These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15680494)

  • 1. Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice.
    Gabra BH; Merino VF; Bader M; Pesquero JB; Sirois P
    Regul Pept; 2005 Apr; 127(1-3):245-8. PubMed ID: 15680494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice.
    Gabra BH; Sirois P
    Inflamm Res; 2004 Dec; 53(12):653-7. PubMed ID: 15654512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor.
    Gabra BH; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):61-7. PubMed ID: 15878325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy.
    Gabra BH; Berthiaume N; Sirois P; Nantel F; Battistini B
    Biol Chem; 2006 Feb; 387(2):127-43. PubMed ID: 16497144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice.
    Catanzaro OL; Dziubecki D; Obregon P; Rodriguez RR; Sirois P
    Neuropeptides; 2010 Apr; 44(2):187-9. PubMed ID: 20092893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice.
    Gabra BH; Sirois P
    Peptides; 2003 Aug; 24(8):1131-9. PubMed ID: 14612183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist.
    Gabra BH; Benrezzak O; Pheng LH; Duta D; Daull P; Sirois P; Nantel F; Battistini B
    J Neuropathol Exp Neurol; 2005 Sep; 64(9):782-9. PubMed ID: 16141788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice.
    Gabra BH; Sirois P
    Neuropeptides; 2003 Feb; 37(1):36-44. PubMed ID: 12637034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist.
    Lawson SR; Gabra BH; Guérin B; Neugebauer W; Nantel F; Battistini B; Sirois P
    Regul Pept; 2005 Jan; 124(1-3):221-4. PubMed ID: 15544863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice.
    Gabra BH; Sirois P
    Eur J Pharmacol; 2002 Dec; 457(2-3):115-24. PubMed ID: 12464357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hyperalgesia after tissue injury and faster recovery of allodynia after nerve injury in the GalR1 knockout mice.
    Malkmus S; Lu X; Bartfai T; Yaksh TL; Hua XY
    Neuropeptides; 2005 Jun; 39(3):217-21. PubMed ID: 15944015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.
    Fox A; Kaur S; Li B; Panesar M; Saha U; Davis C; Dragoni I; Colley S; Ritchie T; Bevan S; Burgess G; McIntyre P
    Br J Pharmacol; 2005 Apr; 144(7):889-99. PubMed ID: 15685199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system.
    Catanzaro O; Capponi JA; Michieli J; Labal E; Di Martino I; Sirois P
    Peptides; 2013 Jun; 44():100-4. PubMed ID: 23528517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Lawson SR; Gabra BH; Nantel F; Battistini B; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):69-78. PubMed ID: 15878326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level.
    Ferreira J; Campos MM; Araújo R; Bader M; Pesquero JB; Calixto JB
    Neuropharmacology; 2002 Dec; 43(7):1188-97. PubMed ID: 12504926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice.
    Rashid MH; Inoue M; Matsumoto M; Ueda H
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1158-64. PubMed ID: 14634040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.
    Talbot S; Chahmi E; Dias JP; Couture R
    J Neuroinflammation; 2010 Jun; 7(1):36. PubMed ID: 20587056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: involvement of endogenous bradykinin.
    Kawabata A; Kawao N; Kitano T; Matsunami M; Satoh R; Ishiki T; Masuko T; Kanke T; Saito N
    Neurosci Lett; 2006 Jul; 402(1-2):167-72. PubMed ID: 16644120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of colonic-inflammation-induced acute visceral hypersensitivity to colorectal distension in Na(v)1.9 knockout mice.
    Martinez V; Melgar S
    Eur J Pain; 2008 Oct; 12(7):934-44. PubMed ID: 18280187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice.
    Ferreira J; Trichês KM; Medeiros R; Cabrini DA; Mori MA; Pesquero JB; Bader M; Calixto JB
    Neuropharmacology; 2008 Mar; 54(3):597-604. PubMed ID: 18164734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.